In a bid to claw back $2.15 billion, the struggling pharmaceutical giant Bayer CEO is doing away with middle managers and 99% of the company’s 1,362-page corporate handbook, allowing nearly 100,000 employees to self-manage.
the company is going boss-less, or as he calls it, moving to “dynamic shared ownership.”
It's the typical 'Privatization and concentration of profits, socialization of costs and responsibilities.'